Nobel Prize in Physiology or Medicine | Current Affairs | Vision IAS
MENU
Home

Periodically curated articles and updates on national and international developments relevant for UPSC Civil Services Examination.

Quick Links

High-quality MCQs and Mains Answer Writing to sharpen skills and reinforce learning every day.

Watch explainer and thematic concept-building videos under initiatives like Deep Dive, Master Classes, etc., on important UPSC topics.

ESC

In Summary

The Nobel Prize recognized discoveries on peripheral immune tolerance, highlighting regulatory T-cells, FOXP3 gene, and their roles in autoimmunity, cancer therapy, and transplant care advancements.

In Summary

The Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell (USA) and Shimon Sakaguchi (Japan) for their discoveries on peripheral immune tolerance.

Nobel laureates Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi, awarded for discoveries on peripheral immune tolerance.

Key Highlights of the Research 

  • Focus Area: 
    • The research centers on the peripheral immune system, which includes immune components outside the central nervous system (brain and spinal cord).
    • Understanding this system is essential for to understand on how immune systems work in determining what should be attacked or protected.
  • Discovery of Regulatory T (Treg) Cells:
    • T-cells are immune cells that defend the body from pathogens, with different T-cells performing specialized functions identified by surface proteins.
    • In 1995, Shimon Sakaguchi discovered a new class called regulatory T-cells, which calm the immune system and prevent it from attacking the host, a mechanism known as peripheral tolerance.
  • FOXP3 Gene and Autoimmunity:
    • Brunkow and Ramsdell advanced the field by studying scurfy mice, which develop severe autoimmune disease.
    • In 2001, they identified the FOXP3 gene as responsible for autoimmunity in these mice and in the human disorder IPEX.
    • This discovery enabled Sakaguchi to demonstrate that the FOXP3 gene controls the development of regulatory T-cells.

Significance

  • Cancer therapies: Tumors can recruit T-cells to evade immunity thus; immunotherapies aim to inhibit T-cell activity to improve treatment effectiveness.
  • Autoimmune & transplant care: Trials aim to enhance Treg formation to treat autoimmune diseases or prevent organ rejection.
Watch Video News Today

Explore Related Content

Discover more articles, videos, and terms related to this topic

Title is required. Maximum 500 characters.

Search Notes

Filter Notes

Loading your notes...
Searching your notes...
Loading more notes...
You've reached the end of your notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria or clear the search.

Saving...
Saved

Please select a subject.

Referenced Articles

linked

No references added yet